@entity6687 does not contraindicate hepatectomy for XXXX .

@entity1 @entity14 @entity3 @entity6687 @entity23719
BACKGROUND: @entity6687 has always been considered an absolute contraindication to hepatectomy for liver @entity3 . The present study reports the long-term outcome and prognostic factors of @entity1 undergoing resection of @entity6687 simultaneously with hepatectomy for liver @entity3 . METHODS: From January 1987 to January 2001, 111 (30 per cent) of 376 @entity1 who had hepatectomy for @entity14 underwent simultaneous resection of @entity6687 with curative intent. RESULTS: Surgery was considered R0 in 77 @entity1 (69 per cent) and palliative ( @entity23719 ) in 34 @entity1 (31 per cent). The mortality rate was 4 per cent and the morbidity rate 28 per cent. After a median follow-up of 4.9 years, the overall 3- and 5-year survival rates were 38 and 20 per cent respectively. The 5-year overall survival rate of @entity1 with R0 resection only (n = 75) was 29 per cent. The difference in survival between @entity1 with and without @entity6687 discovered incidentally at operation was significant, as was the number of liver @entity3 . CONCLUSION: @entity6687 in @entity1 with @entity14 who also have liver @entity3 should no longer be considered an absolute contraindication to hepatectomy. However, the presence of more than five liver @entity3 and the incidental intraoperative discovery of @entity6687 remain contraindications to hepatic resection.
